Brand Name | Status | Last Update |
---|---|---|
technescan hdp | New Drug Application | 2022-12-20 |
technescan mag3 | New Drug Application | 2022-12-13 |
technescan pyp | New Drug Application | 2024-06-07 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | 1 | — | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | 1 | — | 1 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | — | — | 1 | — | 1 |
Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | — | — | — | 1 | — | 1 |
Thalassemia | D013789 | EFO_1001996 | D56 | — | — | — | 1 | — | 1 |
Hemochromatosis | D006432 | EFO_1000642 | E83.11 | — | — | — | 1 | — | 1 |
Hemosiderosis | D006486 | — | — | — | — | — | 1 | — | 1 |
Abdominal pain | D015746 | EFO_0003766 | R10.9 | — | — | — | 1 | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | — | — | 1 | — | 1 |
Infections | D007239 | EFO_0000544 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hematologic neoplasms | D019337 | — | — | — | 1 | 1 | — | — | 2 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Graft vs host disease | D006086 | — | D89.81 | — | 1 | — | — | — | 1 |
Peripheral blood stem cell transplantation | D036102 | — | — | — | 1 | — | — | — | 1 |
Lymphocyte transfusion | D017710 | — | — | — | 1 | — | — | — | 1 |
Leukemia | D007938 | — | C95 | — | 1 | — | — | — | 1 |
Lymphoid leukemia | D007945 | — | C91 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | — | — | 2 | 2 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | — | — | 2 | 2 |
Liver failure | D017093 | — | K72.9 | — | — | — | — | 2 | 2 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | — | — | — | 1 | 1 |
Fatty liver | D005234 | EFO_0003934 | — | — | — | — | — | 1 | 1 |
Cholecystitis | D002764 | — | K81 | — | — | — | — | 1 | 1 |
Acalculous cholecystitis | D042101 | EFO_1000790 | — | — | — | — | — | 1 | 1 |
Dyskinesias | D020820 | — | G24 | — | — | — | — | 1 | 1 |
Biliary dyskinesia | D001657 | EFO_0007169 | — | — | — | — | — | 1 | 1 |
Carcinoma | D002277 | — | C80.0 | — | — | — | — | 1 | 1 |
Drug common name | Lidofenin |
INN | lidofenin |
Description | Lidofenin is an amino acid amide. |
Classification | Small molecule |
Drug class | diagnostic aids ((phenylcarbamoyl) methyl iminodiacetic acid derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cccc(C)c1NC(=O)CN(CC(=O)O)CC(=O)O |
PDB | — |
CAS-ID | 59160-29-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1400608 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | EK22QV7701 (ChemIDplus, GSRS) |